Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2011; 17(26): 3117-3125
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3117
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3117
Figure 4 The somatostatin receptor agonist octreotide inhibits activation of the ghrelin promoter.
Pulmonary carcinoid NCI-H727 cells were transfected with a 2 kb mouse ghrelin promoter construct and treated for 24 h with forskolin, IBMX, octreotide, and interferon γ (IFNγ) alone or in combination, after which the ghrelin promoter response was measured by the dual-luciferase reporter assay system. Octreotide inhibited both basal and IBMX and/or forskolin-induced ghrelin expression. Forskolin and IBMX were dissolved in dimethyl sulfoxide (DMSO). aP < 0.05.
- Citation: Strickertsson JA, Døssing KB, Aabakke AJ, Nilsson HO, Hansen TV, Knigge U, Kjær A, Wadström T, Friis-Hansen L. Interferon-γ inhibits ghrelin expression and secretion via a somatostatin-mediated mechanism. World J Gastroenterol 2011; 17(26): 3117-3125
- URL: https://www.wjgnet.com/1007-9327/full/v17/i26/3117.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i26.3117